Jason J McDougall Selected Research

N- (N- (3- carboxyoxirane- 2- carbonyl)leucyl)isoamylamine

1/2021

Intracellular versus extracellular inhibition of calpain I causes differential effects on pain in a rat model of joint inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason J McDougall Research Topics

Disease

37	Pain (Aches) 08/2021 - 07/2003
30	Inflammation (Inflammations) 08/2021 - 01/2004
19	Arthralgia (Joint Pain) 01/2022 - 10/2005
18	Arthritis (Polyarthritis) 08/2021 - 07/2003
14	Hyperalgesia 01/2021 - 07/2006
13	Osteoarthritis 01/2022 - 07/2006
5	Neuralgia (Stump Neuralgia) 01/2022 - 08/2017
5	Synovitis 01/2021 - 06/2013
4	Neurogenic Inflammation 10/2020 - 01/2016
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2017
3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2017
3	Chronic Pain 09/2017 - 04/2011
2	Hypersensitivity (Allergy) 01/2020 - 01/2016
2	Edema (Dropsy) 08/2017 - 03/2009
2	Infections 02/2011 - 01/2011
2	Cicatrix (Scar) 07/2008 - 09/2006
1	Neuroinflammatory Diseases 10/2020
1	Experimental Arthritis 01/2016
1	Allergic Contact Dermatitis 01/2016
1	Dermatitis 01/2016
1	Contact Dermatitis (Eczema, Contact) 01/2016

Drug/Important Bio-Agent (IBA)

8	Peptide Hydrolases (Proteases)FDA Link 08/2021 - 01/2010
8	CarrageenanIBA 01/2021 - 01/2004
8	NeuropeptidesIBA 10/2020 - 01/2004
8	Analgesics (Analgesic Drugs)IBA 01/2020 - 10/2005
7	Proteinase-Activated ReceptorsIBA 08/2021 - 01/2006
7	KaolinIBA 01/2021 - 01/2004
7	EndocannabinoidsIBA 10/2020 - 05/2011
6	CannabinoidsIBA 10/2020 - 01/2008
4	Serine Proteases (Serine Protease)IBA 08/2021 - 02/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
4	SodiumIBA 11/2020 - 07/2006
4	Peptides (Polypeptides)IBA 01/2016 - 05/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
3	EnzymesIBA 08/2021 - 05/2011
3	Capsaicin (Zostrix)FDA Link 01/2021 - 09/2005
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021 - 02/2016
3	Iodoacetic AcidIBA 01/2021 - 11/2009
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2020 - 08/2011
3	CytokinesIBA 01/2018 - 12/2012
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2017 - 05/2011
3	Opioid Analgesics (Opioids)IBA 04/2011 - 10/2005
3	Ion Channels (Ion Channel)IBA 04/2011 - 11/2005
3	endomorphin 1IBA 10/2005 - 01/2004
2	lysophosphatidic acidIBA 01/2022 - 01/2019
2	Voltage-Gated Sodium ChannelsIBA 01/2019 - 01/2012
2	A 803467IBA 01/2019 - 01/2012
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2017 - 05/2011
2	GalaninIBA 01/2016 - 01/2016
2	Type 3 Galanin ReceptorIBA 01/2016 - 01/2016
2	Sodium Channels (Sodium Channel)IBA 12/2012 - 01/2012
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2006 - 05/2005
2	LigandsIBA 01/2006 - 01/2004
2	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2005 - 04/2004
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	QX-314IBA 01/2021
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	CalpainIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021
1	FlagellinIBA 01/2021
1	protease-activated receptor 4IBA 01/2021
1	calpain inhibitorsIBA 01/2021
1	N- (N- (3- carboxyoxirane- 2- carbonyl)leucyl)isoamylamineIBA 01/2021
1	Cannabinoid Receptor AntagonistsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Monoacylglycerol LipasesIBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	iodopravadoline (AM 630)IBA 01/2020
1	Probenecid (Benemid)FDA LinkGeneric 01/2018
1	Medical MarijuanaIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Drinking WaterIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	CannabidiolIBA 12/2017
1	sivelestatIBA 08/2017
1	TachykininsIBA 09/2016
1	Neurokinin AIBA 09/2016
1	Tryptases (Tryptase)IBA 09/2016
1	Substance PIBA 09/2016
1	Tachykinin Receptors (Tachykinin Receptor)IBA 09/2016
1	2- (5- methylhexahydropyrrolo(3,4- c)pyrrol- 2- yl)xanthen- 9- oneIBA 02/2016
1	methyllycaconitineIBA 02/2016
1	U 0126 (UO 126)IBA 02/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	OxazoloneIBA 01/2016
1	Lysine Carboxypeptidase (Carboxypeptidase N)IBA 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016
1	KininsIBA 01/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016
1	InterleukinsIBA 01/2016
1	AllergensIBA 01/2016

Therapy/Procedure

14	Intra-Articular Injections 01/2022 - 01/2004
6	Therapeutics 01/2020 - 01/2011
1	Injections 01/2021
1	Lasers (Laser) 01/2021
1	Spinal Injections 11/2020
1	Drug Therapy (Chemotherapy) 09/2017